Receptor-specific reversible sedation: beginning of new era of anesthesia?
Talke
P
P
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000758:Anesthesia / Q000379:methods*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000037:antagonists & inhibitors*; D007093:Imidazoles / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D020926:Medetomidine; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D006993:Hypnotics and Sedatives; D007093:Imidazoles; D011942:Receptors, Adrenergic, alpha; C050701:atipamezole; D020926:Medetomidine